ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Revance Therapeutics Inc

Revance Therapeutics Inc (RVNC)

2.66
-0.21
(-7.32%)
Closed June 21 4:00PM
2.66
0.00
( 0.00% )
Pre Market: 4:00AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 28.37M29.02M49.92M49.33M58.13M56.78M69.8M51.94M
Operating Income -57.84M-77.48M-144.41M-58.03M-65.5M-139.29M-53.95M-46.83M
Pre Tax Income -61.44M-83.99M-145.95M-59.79M-67.32M-140.88M-55.7M-49.53M
Net Income -61.44M-84.69M-145.95M-59.79M-67.32M-141.18M-55.7M-53.15M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -58.12M-77.37M-146.21M-58.27M-66.1M-139.52M-53.74M-47.27M
EBITDA -52.39M-72.05M-57.16M-51.41M-61.97M-43.99M-52.53M-44.85M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 300k262k3.73M413k15.33M77.8M132.57M234.04M
Operating Income -79.16M-117.5M-142.63M-164.46M-273.16M-274.68M-341.96M-316.78M
Pre Tax Income -89.27M-120.59M-139.57M-159.43M-284.71M-281.31M-355.72M-323.69M
Net Income -89.27M-120.59M-142.57M-159.43M-282.09M-281.31M-356.42M-323.99M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -3.156-3.302-3.856-3.044-4.078-3.93-4.326-3.689
EBIT -79.69M-118.02M-143.41M-164.76M-273.75M-275.44M-344.14M-317.62M
EBITDA -77.71M-116M-140.91M-161.55M-262.91M-254.82M-238.44M-209.9M

Your Recent History

Delayed Upgrade Clock